Do you want to read an article? Please log in or register.
Psychosis relapse, medication non-adherence, and cannabis
Psychosis and Schizophrenia
Related content
Psychosis and Schizophrenia
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
Lancet Psychiatry.
Schoeler T, Petros N, Di Forti M, Klamerus E, Foglia E, Murray R, Bhattacharyya S
doi: 10.1016/S2215-
Psychosis and Schizophrenia
Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence
Front Psychiatry.
Moulin V, Baumann P, Gholamrezaee M, Alameda L, Palix J, Gasser J, Conus P
doi: 10.3389/fpsyt.2018.00294.
Psychosis and Schizophrenia
Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants
Early Interv Psychiatry.
O'Donoghue B, Francey SM, Nelson B, Ratheesh A, Allott K, Graham J, Baldwin L, Alvarez-Jimenez M, Thompson A, Fornito A, Polari A, Berk M, Macneil C, Crisp K, Pantelis C, Yuen HP, Harrigan S, McGorry P
doi: 10.1111/eip.12716.
Psychosis and Schizophrenia
The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents
J Child Adolesc Ment Health.
Paruk S, Jhazbhay K, Singh K, Sartorius B, Burns JK
doi: 10.2989/
Psychosis and Schizophrenia
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis
Lancet Psychiatry.
Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM
doi: 10.1016/S2215-0366(20)30264-9.
Psychosis and Schizophrenia
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study
Lancet Psychiatry.
Morrison AP, Pyle M, Maughan D, Johns L, Freeman D, Broome MR, Husain N, Fowler D, Hudson J, MacLennan G, Norrie J, Shiers D, Hollis C, James A, MAPS group.
doi: 10.1016/S2215-0366(20)30248-0.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Lancet Neurol.
Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, van der Worp HB, Parides MK, Stefani MA, Houdart E, Libman R, Pile-Spellman J, Harkness K, Cordonnier C, Moquete E, Biondi A, Klijn CJM, Stapf C, Moskowitz AJ, ARUBA co-investigators.
doi: 10.1016/S1474-4422(20)30181-2.
RECOMMENDED
Bipolar Disorder
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors
J Affect Disord.
Fung VC, Overhage LN, Sylvia LG, Reilly-Harrington NA, Kamali M, Gao K, Shelton RC, Ketter TA, Bobo WV, Thase ME, Calabrese JR, Tohen M, Deckersbach T, Nierenberg AA
doi: 10.1016/j.jad.2019.06.050.
Psychosis and Schizophrenia
Psychosis and synthetic cannabinoids
Psychiatry Res.
Deng H, Verrico CD, Kosten TR, Nielsen DA
doi: 10.1016/j.psychres.